As of 2024-12-13, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 17.0x | 16.0x |
| Forward P/E multiples | 15.4x - 21.2x | 15.7x |
| Fair Price | (22.13) - (24.60) | (22.85) |
| Upside | -157.9% - -164.4% | -159.8% |
| Date | EV/EBITDA |